{
    "clinical_study": {
        "@rank": "90804", 
        "arm_group": {
            "arm_group_label": "ultrasonic, erythritol, metronidazole gel", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "20 consecutive adult implant patients, presenting the signs of peri-implant mucositis\n      (probing depth \u22654 mm combined with bleeding and/or pus on probing) or  initial\n      peri-implantitis (probing depth \u22654 mm, bleeding and suppuration  plus radiographic loss of\n      supporting bone \u226430% compared with the situation after implant placement) will be included.\n\n      Sites will be treated by ultrasonic debridement of the pocket, performed using a\n      piezoceramic ultrasonic device. For the purpose,  a  Tip will be connected to the\n      Handpiece Led (5 minutes/pocket) . Then, it will be followed by the  subgingival use of\n      erythritol powder applied by the use of Handpiece  connected to an airflow unit 2x5\n      seconds/pocket. At this time the subgingival delivery of metronidazole gel will be provided.\n       After instrumentation, patients will rinse with chlorhexidine 0.20% 3 times/day for 2\n      weeks.\n\n      At baseline, 1 month, 3 months and 6 months the following parameters will be evaluated:\n      Probing Pocket depth (PPD), Bleeding on Probing (BoP), Clinical Attachment Level (CAL)."
        }, 
        "brief_title": "Non Surgical Treatment of Periimplantitis", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Peri-Implantitis and Peri-implant Mucositis", 
        "condition_browse": {
            "mesh_term": [
                "Mucositis", 
                "Peri-Implantitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  adult patients suffering from peri-implant mucositis or peri-implantitis\n\n        Exclusion Criteria:\n\n          -  Heavy smokers current pregnant history of malignancy long-term steroidal or\n             antibiotic therapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02023853", 
            "org_study_id": "Proed.08.2013.periimplantitis"
        }, 
        "intervention": [
            {
                "arm_group_label": "ultrasonic, erythritol, metronidazole gel", 
                "intervention_name": "ultrasonic", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "ultrasonic, erythritol, metronidazole gel", 
                "intervention_name": "erythritol", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "ultrasonic, erythritol, metronidazole gel", 
                "intervention_name": "metronidazole gel", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Erythritol", 
                "Metronidazole"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 24, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Torino", 
                    "country": "Italy", 
                    "zip": "10129"
                }, 
                "name": "PROED, Institute for Professional Education in Dentistry"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Use of Erythritol Powder and Locally Derived Metronidazole for the Non-surgical Treatment of Peri-implant Mucositis and Peri-implantitis.", 
        "overall_contact": {
            "email": "dacardar@tin.it", 
            "last_name": "Daniele Cardaropoli, DDS", 
            "phone": "+39.338.6688933"
        }, 
        "overall_official": {
            "affiliation": "Proed", 
            "last_name": "Daniele Cardaropoli, DDS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "probing pocket depth change", 
                "safety_issue": "No", 
                "time_frame": "baseline, 6 months"
            }, 
            {
                "measure": "bleeding on probing change", 
                "safety_issue": "No", 
                "time_frame": "baseline, 6 months"
            }, 
            {
                "measure": "clinical attachment level change", 
                "safety_issue": "No", 
                "time_frame": "baseline, 6 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02023853"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Proed", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Proed", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}